valid 
patent racem citalopram method obtain enantiom 
patente also held previou patent racem 
racem enantiom drug treatment depress 
claim therapeut effect citalopram 
challeng valid claim 
construct claim 
whether independ exist molecul whether also part racem 
whether claim anticip patent citalopram 
whether independ molecul obviou 
australian test obvious 
applic test product claim method claim method obtain 
lack util 
product claim dosag inter alia less use dosag rang held upon proper construct product claim independ exist enantiom invent independ exist enantiom anticip patent racem australian matter routin test obvious appli invent product equat question whether skill art matter routin would goal obtain separ enantiom expect one would desir drug treatment depress one product claim relat dosag fail test util evid neither method obtain obviou prioriti date 
extens term 
patent racem citalopram method obtain enantiom 
patente also held previou patent racem 
racem enantiom drug treatment depress 
claim therapeut effect citalopram 
cipramil good base racem citalopram lexapro good base enter australian regist therapeut good artg 
applic extens term patent 
commission patent initi grant extens sought 
subsequ follow hear deleg decid reduc term extens ground first regulatori approv date date good cipramil base racem enter artg 
appeal patente 
oppon pharmaceut compani contend extens grant applic extens made outsid six month period follow date first inclus artg good contain name cipramil activ pharmaceut substanc racem 
question proper construct patent act cth ss 
whether good base racem contain individu enantiom 
mean first regulatori approv date act held cipramil contain pharmaceut substanc applic extens term patent made within six month first inclus artg cipramil circumst commission lack power grant extens term patent regist patent rectifi remov particular extens 
infring 
patent racem citalopram method obtain enantiom 
gener compani appli therapeut good administr tga registr gener drug base citalopram 
whether doctrin mechan equival integ applic method obtain pharmaceut compound 
gener pharmaceut compani produc gener drug purpos appli regulatori approv 
patent act cth held doctrin mechan equival appli certain differ step method prevent gener compani method infring method subject patent infring reason 
therapeut good act cth tg act 
protect inform 
patente held earlier patent racem citalopram later patent one enantiom 
registr australian regist therapeut good artg therapeut good cipramil racem activ compon 
later registr artg therapeut good lexapro activ compon 
gener compani appli registr artg good activ compon 
question whether inform patente suppli therapeut good administr tga connect applic regist lexapro could use tga connect gener compani applic regist gener drug 
tg act effect certain inform therapeut good use evalu therapeut good registr artg 
whether inform suppli patente applic registr lexapro protect inform respect gener compani applic regist gener drug 
question whether cipramil good contain purpos c tg act held cipramil contain inform given patente relat registr lexapro therefor protect inform could use tga evalu gener compani applic regist gener drug 
expert opinion evid 
professor psychiatri cite carri clinic studi result purpos show patent enantiom far greater therapeut effect previous patent racem 
clinic studi carri prioriti date 
whether surprisingli favour result relev 
whether citat clinic studi result admiss 
whether order made evid act cth limit use made psychiatrist evid held carri clinic studi prioriti date patent result studi irrelev state common gener knowledg prioriti date therefor prob issu obvious citat clinic studi result render inadmiss failur prove otherwis psychiatrist hearsay evid evid act cth appli clinic studi result cite psychiatrist order made act 
patent 
patent 
patent 
patent 
evid 

